kynurenine has been researched along with Blood Pressure, High in 12 studies
Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Aim To compare serum concentrations of tryptophane (Trp) and its metabolites in subjects with no cardiovascular disease (CVD) and patients with СVD, including arterial hypertension (AH) and ischemic heart disease (IHD)." | 8.12 | Comparative analysis of tryptophan and downstream metabolites of the kynurenine and serotonin pathways in patients with arterial hypertension and coronary artery disease. ( Ageev, AA; Appolonova, SA; Belenkov, YN; Korobkova, EO; Kozhevnikova, MV; Krivova, AV; Moskaleva, NE; Privalova, EV; Shestakova, KM, 2022) |
| "In symptomatic patients with severe aortic stenosis undergoing transcatheter aortic valve replacement, circulating levels of long-chain acylcarnitines were independently associated with measures of maladaptive LV remodeling, and metabolic perturbations lessened after procedure completion." | 7.88 | Association of Acylcarnitines With Left Ventricular Remodeling in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement. ( Elmariah, S; Farrell, LA; Furman, D; Gerszten, RE; Lindman, BR; Morningstar, JE; Rhee, EP; Shi, X, 2018) |
| " It was found that in a part of patients the long-term administration of antihypertensive drugs led to an increased accumulation of kynurenine as a manifestation of pyridoxal-5-phosphate deficiency." | 5.28 | Increased blood kynurenine level as a factor inhibiting the therapeutic effect of antihypertensive agents in combined long-term treatment of essential hypertension. ( Liepinja, DJ; Rudzite, VK; Silava, AK; Vitols, AV, 1990) |
| "Aim To compare serum concentrations of tryptophane (Trp) and its metabolites in subjects with no cardiovascular disease (CVD) and patients with СVD, including arterial hypertension (AH) and ischemic heart disease (IHD)." | 4.12 | Comparative analysis of tryptophan and downstream metabolites of the kynurenine and serotonin pathways in patients with arterial hypertension and coronary artery disease. ( Ageev, AA; Appolonova, SA; Belenkov, YN; Korobkova, EO; Kozhevnikova, MV; Krivova, AV; Moskaleva, NE; Privalova, EV; Shestakova, KM, 2022) |
| "In symptomatic patients with severe aortic stenosis undergoing transcatheter aortic valve replacement, circulating levels of long-chain acylcarnitines were independently associated with measures of maladaptive LV remodeling, and metabolic perturbations lessened after procedure completion." | 3.88 | Association of Acylcarnitines With Left Ventricular Remodeling in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement. ( Elmariah, S; Farrell, LA; Furman, D; Gerszten, RE; Lindman, BR; Morningstar, JE; Rhee, EP; Shi, X, 2018) |
| " It was found that in a part of patients the long-term administration of antihypertensive drugs led to an increased accumulation of kynurenine as a manifestation of pyridoxal-5-phosphate deficiency." | 1.28 | Increased blood kynurenine level as a factor inhibiting the therapeutic effect of antihypertensive agents in combined long-term treatment of essential hypertension. ( Liepinja, DJ; Rudzite, VK; Silava, AK; Vitols, AV, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 3 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 4 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Dupont, V | 1 |
| Berg, AH | 1 |
| Yamashita, M | 1 |
| Huang, C | 1 |
| Covarrubias, AE | 1 |
| Ali, S | 1 |
| Stotland, A | 1 |
| Van Eyk, JE | 1 |
| Jim, B | 2 |
| Thadhani, R | 1 |
| Karumanchi, SA | 1 |
| Kozhevnikova, MV | 2 |
| Krivova, AV | 2 |
| Korobkova, EO | 2 |
| Ageev, AA | 2 |
| Shestakova, KM | 2 |
| Moskaleva, NE | 2 |
| Appolonova, SA | 2 |
| Privalova, EV | 2 |
| Belenkov, YN | 2 |
| Theiler-Schwetz, V | 1 |
| Trummer, C | 1 |
| Grübler, MR | 1 |
| Keppel, MH | 1 |
| Zittermann, A | 1 |
| Tomaschitz, A | 1 |
| März, W | 1 |
| Meinitzer, A | 1 |
| Pilz, S | 1 |
| Gupta, S | 1 |
| Petras, L | 1 |
| Tufail, MU | 1 |
| Rodriguez Salazar, JD | 1 |
| Elmariah, S | 1 |
| Farrell, LA | 1 |
| Furman, D | 1 |
| Lindman, BR | 1 |
| Shi, X | 1 |
| Morningstar, JE | 1 |
| Rhee, EP | 1 |
| Gerszten, RE | 1 |
| Zhao, J | 2 |
| Passos, CS | 1 |
| Carvalho, LN | 1 |
| Pontes, RB | 1 |
| Campos, RR | 1 |
| Ikuta, O | 1 |
| Boim, MA | 1 |
| Martinsons, A | 1 |
| Rudzite, V | 2 |
| Jurika, E | 1 |
| Silava, A | 1 |
| Sileniece, G | 1 |
| Liepina, D | 1 |
| Dalmane, A | 1 |
| Zirne, R | 1 |
| Rudzite, VK | 1 |
| Vitols, AV | 1 |
| Liepinja, DJ | 1 |
| Silava, AK | 1 |
| Rudzit, VK | 1 |
| Silenietse, GO | 1 |
| Zirne, RA | 1 |
| Iurika, EV | 1 |
1 review available for kynurenine and Blood Pressure, High
| Article | Year |
|---|---|
Hypertension in Pregnancy: What We Now Know.
Topics: Animals; Female; Fetus; Humans; Hypertension; Kynurenine; Mice; Pre-Eclampsia; Pregnancy | 2023 |
1 trial available for kynurenine and Blood Pressure, High
| Article | Year |
|---|---|
Plasma kynurenic acid/tryptophan ratio: a sensitive and reliable biomarker for the assessment of renal function.
Topics: Adult; Aged; Chromatography, High Pressure Liquid; Female; Humans; Hypertension; Kidney Function Tes | 2013 |
10 other studies available for kynurenine and Blood Pressure, High
| Article | Year |
|---|---|
Impaired renal reserve contributes to preeclampsia via the kynurenine and soluble fms-like tyrosine kinase 1 pathway.
Topics: Animals; Female; Humans; Hypertension; Ischemia; Kidney; Kynurenine; Mice; Nephrectomy; Placenta; Pl | 2022 |
Comparative analysis of tryptophan and downstream metabolites of the kynurenine and serotonin pathways in patients with arterial hypertension and coronary artery disease.
Topics: Atherosclerosis; Coronary Artery Disease; Humans; Hydroxyindoleacetic Acid; Hypertension; Kynurenic | 2022 |
Comparative analysis of tryptophan and downstream metabolites of the kynurenine and serotonin pathways in patients with arterial hypertension and coronary artery disease.
Topics: Atherosclerosis; Coronary Artery Disease; Humans; Hydroxyindoleacetic Acid; Hypertension; Kynurenic | 2022 |
Comparative analysis of tryptophan and downstream metabolites of the kynurenine and serotonin pathways in patients with arterial hypertension and coronary artery disease.
Topics: Atherosclerosis; Coronary Artery Disease; Humans; Hydroxyindoleacetic Acid; Hypertension; Kynurenic | 2022 |
Comparative analysis of tryptophan and downstream metabolites of the kynurenine and serotonin pathways in patients with arterial hypertension and coronary artery disease.
Topics: Atherosclerosis; Coronary Artery Disease; Humans; Hydroxyindoleacetic Acid; Hypertension; Kynurenic | 2022 |
Associations of Parameters of the Tryptophan-Kynurenine Pathway with Cardiovascular Risk Factors in Hypertensive Patients.
Topics: Cardiovascular Diseases; Cross-Sectional Studies; Heart Disease Risk Factors; Humans; Hypertension; | 2023 |
Association of Acylcarnitines With Left Ventricular Remodeling in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement.
Topics: Aged, 80 and over; Aortic Valve Stenosis; Biomarkers; Carnitine; Choline; Diabetes Complications; Fe | 2018 |
Simultaneous determination of plasma creatinine, uric acid, kynurenine and tryptophan by high-performance liquid chromatography: method validation and in application to the assessment of renal function.
Topics: Adult; Aged; Chromatography, High Pressure Liquid; Creatinine; Female; Humans; Hypertension; Kidney | 2015 |
Blood pressure reducing effects of Phalaris canariensis in normotensive and spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Disease Models, Animal; Dose-Response Relationship | 2012 |
The relationship between kynurenine, catecholamines, and arterial hypertension in mesangioproliferative glomerulonephritis.
Topics: Blood Pressure; Catecholamines; Diastole; Dopamine; Epinephrine; Glomerulonephritis, Membranoprolife | 1996 |
Impairment of kynurenine metabolism in cardiovascular disease.
Topics: Animals; Antihypertensive Agents; Cardiomyopathies; Cells, Cultured; Humans; Hypertension; Isoniazid | 1991 |
Increased blood kynurenine level as a factor inhibiting the therapeutic effect of antihypertensive agents in combined long-term treatment of essential hypertension.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Cardiac Volume; Cardiomegaly; Clonidine; Drug Therap | 1990 |
[Kynureninemia in patients with hypertension and ischemic heart disease previously treated with antitubercular drugs].
Topics: Antitubercular Agents; Coronary Disease; Humans; Hypertension; Kynurenine; Tuberculosis, Pulmonary | 1988 |